Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
snake venom antiserum
- Development stage
- Unknown
- Lead developer
- VINS Bio Products
- Modality
- Antibody-Based Therapeutics
- Administration
- Intravenous
01
Overview
**Snake venom antiserum** is a Vins Bioproducts polyvalent equine antivenom for the emergency treatment of envenomation by the Indian cobra, common krait, Russell's viper, and saw-scaled viper. It contains purified polyclonal equine immunoglobulin fragments generated by hyperimmunizing horses with these venoms; the antibodies bind and neutralize circulating venom toxins, helping limit neurotoxic, hemotoxic, and local tissue effects. The product is supplied as liquid antivenom or lyophilized material for reconstitution and intravenous administration. ([vinsbio.in](https://vinsbio.in/anti-venom/))
- Other names
- Anti-snake venom serumASVSequine polyvalent snake antivenompolyvalent snake venom antiserumsnake antivenom (equine polyvalent)snake venom antiserum I.P.
02
Targets
SVMP (Snake venom metalloproteinase)svPLA2 (Snake venom phospholipase A2)3FTx (Snake venom three-finger toxins)
Beyond the preview
Go deeper on snake venom antiserum.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on snake venom antiserum.